BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37248033)

  • 1. Genotypes and phenotypes of
    Kim J; Teng LY; Shaker B; Na D; Koh HY; Kwon SS; Lee JS; Kim HD; Kang HC; Kim SH
    J Med Genet; 2023 Nov; 60(11):1076-1083. PubMed ID: 37248033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autism and mild epilepsy associated with a de novo missense pathogenic variant in the GTPase effector domain of DNM1.
    Mei D; Parrini E; Bianchini C; Ricci ML; Guerrini R
    Am J Med Genet C Semin Med Genet; 2023 May; ():. PubMed ID: 37132416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deep intronic variant in DNM1 in a patient with developmental and epileptic encephalopathy creates a splice acceptor site and affects only transcript variants including exon 10a.
    Harms FL; Weiss D; Lisfeld J; Alawi M; Kutsche K
    Neurogenetics; 2023 Jul; 24(3):171-180. PubMed ID: 37039969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncated DNM1 variant underlines developmental delay and epileptic encephalopathy.
    Afsar T; Huang X; Shah AA; Abbas S; Bano S; Mahmood A; Hu J; Razak S; Umair M
    Front Pediatr; 2023; 11():1266376. PubMed ID: 37900685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal axonal development and severe epileptic phenotype in Dynamin-1 (DNM1) encephalopathy.
    Matsubara K; Kuki I; Ishioka R; Yamada N; Fukuoka M; Inoue T; Nukui M; Okamoto N; Mizuguchi T; Matsumoto N; Okazaki S
    Epileptic Disord; 2024 Feb; 26(1):139-143. PubMed ID: 38009673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function variants in
    Yigit G; Sheffer R; Daana M; Li Y; Kaygusuz E; Mor-Shakad H; Altmüller J; Nürnberg P; Douiev L; Kaulfuss S; Burfeind P; Wollnik B; Brockmann K
    J Med Genet; 2022 Jun; 59(6):549-553. PubMed ID: 34172529
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    von Spiczak S; Helbig KL; Shinde DN; Huether R; Pendziwiat M; Lourenço C; Nunes ME; Sarco DP; Kaplan RA; Dlugos DJ; Kirsch H; Slavotinek A; Cilio MR; Cervenka MC; Cohen JS; McClellan R; Fatemi A; Yuen A; Sagawa Y; Littlejohn R; McLean SD; Hernandez-Hernandez L; Maher B; Møller RS; Palmer E; Lawson JA; Campbell CA; Joshi CN; Kolbe DL; Hollingsworth G; Neubauer BA; Muhle H; Stephani U; Scheffer IE; Pena SDJ; Sisodiya SM; Helbig I; ;
    Neurology; 2017 Jul; 89(4):385-394. PubMed ID: 28667181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, Radiological, and Genetic Characterization of a Patient with a Novel Homoallelic Loss-of-Function Variant in
    AlTassan R; AlQudairy H; Alromayan R; Alfalah A; AlHarbi OA; González-Álvarez AC; Arold ST; Kaya N
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recurrent de novo splice site variant involving DNM1 exon 10a causes developmental and epileptic encephalopathy through a dominant-negative mechanism.
    Parthasarathy S; Ruggiero SM; Gelot A; Soardi FC; Ribeiro BFR; Pires DEV; Ascher DB; Schmitt A; Rambaud C; Represa A; Xie HM; Lusk L; Wilmarth O; McDonnell PP; Juarez OA; Grace AN; Buratti J; Mignot C; Gras D; Nava C; Pierce SR; Keren B; Kennedy BC; Pena SDJ; Helbig I; Cuddapah VA
    Am J Hum Genet; 2022 Dec; 109(12):2253-2269. PubMed ID: 36413998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIGN encephalopathy: Characterizing the epileptology.
    Bayat A; de Valles-Ibáñez G; Pendziwiat M; Knaus A; Alt K; Biamino E; Bley A; Calvert S; Carney P; Caro-Llopis A; Ceulemans B; Cousin J; Davis S; des Portes V; Edery P; England E; Ferreira C; Freeman J; Gener B; Gorce M; Heron D; Hildebrand MS; Jezela-Stanek A; Jouk PS; Keren B; Kloth K; Kluger G; Kuhn M; Lemke JR; Li H; Martinez F; Maxton C; Mefford HC; Merla G; Mierzewska H; Muir A; Monfort S; Nicolai J; Norman J; O'Grady G; Oleksy B; Orellana C; Orec LE; Peinhardt C; Pronicka E; Rosello M; Santos-Simarro F; Schwaibold EMC; Stegmann APA; Stumpel CT; Szczepanik E; Terczyńska I; Thevenon J; Tzschach A; Van Bogaert P; Vittorini R; Walsh S; Weckhuysen S; Weissman B; Wolfe L; Reymond A; De Nittis P; Poduri A; Olson H; Striano P; Lesca G; Scheffer IE; Møller RS; Sadleir LG
    Epilepsia; 2022 Apr; 63(4):974-991. PubMed ID: 35179230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Assessments and EEG Analyses of Encephalopathies Associated With Dynamin-1 Mutation.
    Li H; Fang F; Xu M; Liu Z; Zhou J; Wang X; Wang X; Han T
    Front Pharmacol; 2019; 10():1454. PubMed ID: 31920647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-Based Gene Therapy Rescues Developmental and Epileptic Encephalopathy in a Genetic Mouse Model.
    Aimiuwu OV; Fowler AM; Sah M; Teoh JJ; Kanber A; Pyne NK; Petri S; Rosenthal-Weiss C; Yang M; Harper SQ; Frankel WN
    Mol Ther; 2020 Jul; 28(7):1706-1716. PubMed ID: 32353324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCN1B Genetic Variants: A Review of the Spectrum of Clinical Phenotypes and a Report of Early Myoclonic Encephalopathy.
    Zhu Z; Bolt E; Newmaster K; Osei-Bonsu W; Cohen S; Cuddapah VA; Gupta S; Paudel S; Samanta D; Dang LT; Carney PR; Naik S
    Children (Basel); 2022 Oct; 9(10):. PubMed ID: 36291443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo DNM1 mutations in two cases of epileptic encephalopathy.
    Nakashima M; Kouga T; Lourenço CM; Shiina M; Goto T; Tsurusaki Y; Miyatake S; Miyake N; Saitsu H; Ogata K; Osaka H; Matsumoto N
    Epilepsia; 2016 Jan; 57(1):e18-23. PubMed ID: 26611353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamin-1-related infantile spasms: a case report and review of literature].
    Deng XL; Yin F; Zhang CL; Ma YP; He F; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2016 Nov; 54(11):856-859. PubMed ID: 27806796
    [No Abstract]   [Full Text] [Related]  

  • 16. The epileptology of Wiedemann-Steiner syndrome: Electroclinical findings in five patients with KMT2A pathogenic variants.
    Sahly AN; Srour M; Buhas D; Scheffer IE; Myers KA
    Eur J Paediatr Neurol; 2023 May; 44():46-50. PubMed ID: 37075569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the PH Domain of DNM1 are associated with a nonepileptic phenotype characterized by developmental delay and neurobehavioral abnormalities.
    Brereton E; Fassi E; Araujo GC; Dodd J; Telegrafi A; Pathak SJ; Shinawi M
    Mol Genet Genomic Med; 2018 Mar; 6(2):294-300. PubMed ID: 29397573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo variants in PHF21A cause intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures: A case report and literature review.
    Chen H; Chen Y; Wu H; Qiu X; Yu X; Wang R; Zhong J; Peng J
    Seizure; 2023 Oct; 111():138-146. PubMed ID: 37633153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular and phenotypic spectrum of IQSEC2-related epilepsy.
    Zerem A; Haginoya K; Lev D; Blumkin L; Kivity S; Linder I; Shoubridge C; Palmer EE; Field M; Boyle J; Chitayat D; Gaillard WD; Kossoff EH; Willems M; Geneviève D; Tran-Mau-Them F; Epstein O; Heyman E; Dugan S; Masurel-Paulet A; Piton A; Kleefstra T; Pfundt R; Sato R; Tzschach A; Matsumoto N; Saitsu H; Leshinsky-Silver E; Lerman-Sagie T
    Epilepsia; 2016 Nov; 57(11):1858-1869. PubMed ID: 27665735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamin 1 isoform roles in a mouse model of severe childhood epileptic encephalopathy.
    Asinof S; Mahaffey C; Beyer B; Frankel WN; Boumil R
    Neurobiol Dis; 2016 Nov; 95():1-11. PubMed ID: 27363778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.